首页> 外文期刊>Nucleic acids research >A novel fluorometric oligonucleotide assay to measure O 6-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase
【24h】

A novel fluorometric oligonucleotide assay to measure O 6-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase

机译:一种新颖的荧光寡核苷酸测定法,用于测量O 6-甲基鸟嘌呤DNA甲基转移酶,甲基嘌呤DNA糖基化酶,8-氧代鸟嘌呤DNA糖基化酶和无碱基内切核酸酶活性:过表达甲基嘌呤DNA糖基化酶的人乳腺癌细胞的DNA修复状态

获取原文
       

摘要

DNA repair status plays a major role in mutagenesis, carcinogenesis and resistance to genotoxic agents. Because DNA repair processes involve multiple enzymatic steps, understanding cellular DNA repair status has required several assay procedures. We have developed a novel in vitro assay that allows quantitative measurement of alkylation repair via O6‐methylguanine DNA methyltransferase (MGMT) and base excision repair (BER) involving methylpurine DNA glycosylase (MPG), human 8-oxoguanine DNA glycosylase (hOGG1) and yeast and human abasic endonuclease (APN1 and APE/ref-1, respectively) from a single cell extract. This approach involves preparation of cell extracts in a common buffer in which all of the DNA repair proteins are active and the use of fluorometrically labeled oligonucleotide substrates containing DNA lesions specific to each repair protein. This method enables methylation and BER capacities to be determined rapidly from a small amount of starting sample. In addition, the stability of the fluorometric oligonucleotides precludes the substrate variability caused by continual radiolabeling. In this report this technique was applied to human breast carcinoma MDA-MB231 cells overexpressing human MPG in order to assess whether up-regulation of the initial step in BER alters the activity of selected other BER (hOGG1 and APE/ref-1) or direct reversal (MGMT) repair activities.
机译:DNA修复状态在诱变,致癌作用和对遗传毒性剂的抗性中起主要作用。由于DNA修复过程涉及多个酶促步骤,因此了解细胞DNA修复状态需要几种测定步骤。我们开发了一种新型的体外测定方法,该方法可以通过O 6 -甲基鸟嘌呤DNA甲基转移酶(MGMT)和涉及甲基嘌呤DNA糖基化酶(MPG)的碱基切除修复(BER)定量测量烷基化修复,人8氧鸟嘌呤DNA糖基化酶(hOGG1)和酵母和人无碱基内切核酸酶(分别为APN1和APE / ref-1)。这种方法包括在所有DNA修复蛋白都具有活性的通用缓冲液中制备细胞提取物,并使用荧光标记的寡核苷酸底物,其中含有对每种修复蛋白特异的DNA损伤。该方法可以从少量的起始样品中快速测定甲基化和BER容量。另外,荧光寡核苷酸的稳定性排除了由连续放射性标记引起的底物可变性。在本报告中,该技术用于过表达人MPG的人乳腺癌MDA-MB231细胞,以便评估BER初始步骤的上调是否会改变所选其他BER(hOGG1和APE / ref-1)的活性或直接逆转(MGMT)维修活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号